124 related articles for article (PubMed ID: 8098331)
1. Proliferating cell nuclear antigen (PCNA) in medullary thyroid carcinoma.
Skopelitou A; Korkolopoulou P; Papanikolaou A; Hadjiyannakis M
J Cancer Res Clin Oncol; 1993; 119(7):379-81. PubMed ID: 8098331
[TBL] [Abstract][Full Text] [Related]
2. [Proliferating cell nuclear antigen/cyclin (PCNA/Cyclin) in thyroid carcinoma].
Xu YJ
Zhonghua Wai Ke Za Zhi; 1993 Oct; 31(10):628-9. PubMed ID: 7913437
[TBL] [Abstract][Full Text] [Related]
3. Proliferative activity of human thyroid tumors evaluated by proliferating cell nuclear antigen/cyclin immunohistochemical studies.
Shimizu T; Usuda N; Yamanda T; Sugenoya A; Iida F
Cancer; 1993 May; 71(9):2807-12. PubMed ID: 8096795
[TBL] [Abstract][Full Text] [Related]
4. Proliferating cell nuclear antigen immunostaining in breast cancer and its relation to prognosis.
Narita T; Funahashi H; Satoh Y; Takagi H
Jpn J Clin Oncol; 1993 Feb; 23(1):20-5. PubMed ID: 8096256
[TBL] [Abstract][Full Text] [Related]
5. Prediction of early relapse and shortened survival in patients with breast cancer by proliferating cell nuclear antigen score.
Tahan SR; Neuberg DS; Dieffenbach A; Yacoub L
Cancer; 1993 Jun; 71(11):3552-9. PubMed ID: 8098267
[TBL] [Abstract][Full Text] [Related]
6. Proliferating cell nuclear antigen labeling index of preoperative biopsy specimens in gastric carcinoma with special reference to prognosis.
Maeda K; Chung YS; Onoda N; Kato Y; Nitta A; Arimoto Y; Yamada N; Kondo Y; Sowa M
Cancer; 1994 Feb; 73(3):528-33. PubMed ID: 7905361
[TBL] [Abstract][Full Text] [Related]
7. Proliferating cell nuclear antigen (PCNA) as a prognostic factor in non-Hodgkin's lymphoma.
Klemi PJ; Alanen K; Jalkanen S; Joensuu H
Br J Cancer; 1992 Oct; 66(4):739-43. PubMed ID: 1358164
[TBL] [Abstract][Full Text] [Related]
8. Poor prognostic value of proliferating cell nuclear antigen labelling index in breast carcinoma.
Thomas M; Noguchi M; Kitagawa H; Kinoshita K; Miyazaki I
J Clin Pathol; 1993 Jun; 46(6):525-8. PubMed ID: 8101192
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value of N-myc immunoreactivity in medullary thyroid carcinoma.
Roncalli M; Viale G; Grimelius L; Johansson H; Wilander E; Alfano RM; Springall D; Battezzati PM; Polak JM; Coggi G
Cancer; 1994 Jul; 74(1):134-41. PubMed ID: 7911734
[TBL] [Abstract][Full Text] [Related]
10. Proliferating cell nuclear antigen in archival surgical specimens of malignant lymphoma and metastatic carcinoma: immunohistochemical and flow cytometric analysis.
Gorczyca W; Kram A; Tuziak T; Darzynkiewicz Z; Melamed MR
Patol Pol; 1993; 44(3):121-8. PubMed ID: 7902557
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of proliferating cell nuclear antigen (PCNA) expression in non-small cell lung cancer.
Fujii M; Motoi M; Saeki H; Aoe K; Moriwaki S
Acta Med Okayama; 1993 Apr; 47(2):103-8. PubMed ID: 8099466
[TBL] [Abstract][Full Text] [Related]
12. Proliferating cell nuclear antigen immunohistochemistry using monoclonal antibody 19A2 and a new antigen retrieval technique has prognostic impact in archival paraffin-embedded node-negative breast cancer.
Siitonen SM; Kallioniemi OP; Isola JJ
Am J Pathol; 1993 Apr; 142(4):1081-9. PubMed ID: 7682759
[TBL] [Abstract][Full Text] [Related]
13. Proliferating cell nuclear antigen (PCNA), immunostaining and flow cytometric DNA analysis of renal cell carcinoma.
Tanioka F; Hiroi M; Yamane T; Hara H
Zentralbl Pathol; 1993 Aug; 139(3):185-93. PubMed ID: 8105885
[TBL] [Abstract][Full Text] [Related]
14. Differences in cell proliferation and prognostic significance of proliferating cell nuclear antigen and Ki-67 antigen immunoreactivity in in situ and invasive carcinomas of the extrahepatic biliary tract.
Lee CS
Cancer; 1996 Nov; 78(9):1881-7. PubMed ID: 8909306
[TBL] [Abstract][Full Text] [Related]
15. Proliferating cell nuclear antigen and nucleolar organizer regions in CNS tumors: correlation with histological type and tumor grade. A comparative study of 82 cases on paraffin sections.
Korkolopoulou P; Christodoulou P; Papanikolaou A; Thomas-Tsagli E
Am J Surg Pathol; 1993 Sep; 17(9):912-9. PubMed ID: 8102513
[TBL] [Abstract][Full Text] [Related]
16. The prognostic significance of proliferating cell nuclear antigen in clinical gastric cancer.
Mori M; Kakeji Y; Adachi Y; Moriguchi S; Maehara Y; Sugimachi K; Jessup JM; Chen LB; Steele GD
Surgery; 1993 Jun; 113(6):683-90. PubMed ID: 8099452
[TBL] [Abstract][Full Text] [Related]
17. [Immunohistochemical investigation of proliferating cell nuclear antigen in bladder cancer].
Sumiyoshi Y; Inoue Y; Akiyama M
Nihon Hinyokika Gakkai Zasshi; 1993 Sep; 84(9):1643-8. PubMed ID: 8105131
[TBL] [Abstract][Full Text] [Related]
18. The expression of proliferating cell nuclear antigen in hepatocellular carcinoma.
Wu JD; Tseng HH
Zhonghua Yi Xue Za Zhi (Taipei); 1994 Apr; 53(4):198-203. PubMed ID: 7911731
[TBL] [Abstract][Full Text] [Related]
19. Expression of proliferating cell nuclear antigen (PCNA) in gastric carcinoma: no evidence for prognostic value.
Mangham DC; Rowlands DC; Newbold KM; Reynolds GM; Fielding JW; Hallissey MT
J Clin Pathol; 1994 May; 47(5):473-4. PubMed ID: 7913101
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical study of medullary thyroid carcinoma: relationship of clinical features to prognostic factors in 36 patients.
Takami H; Bessho T; Kameya T; Mimura T; Ito K; Abe O; Hosoda Y; Shikata J
World J Surg; 1988 Aug; 12(4):572-9. PubMed ID: 3048002
[No Abstract] [Full Text] [Related]
[Next] [New Search]
